<?xml version="1.0" encoding="UTF-8"?>
<p>Viral hemorrhagic fevers (VHFs), which refer to a group of illnesses that are caused by viruses within a distinct group of families, are well known for their characteristic overall vascular system damage and the impairment of the body’s ability to regulate itself [
 <xref rid="pone.0208907.ref001" ref-type="bibr">1</xref>]. Symptoms presented by VHF-related illnesses are often accompanied by hemorrhage which in itself is rarely life-threatening [
 <xref rid="pone.0208907.ref001" ref-type="bibr">1</xref>]. While some types of hemorrhagic fever viruses cause relatively mild illness, many of these viruses cause severe fatal disease. The occurrence of outbreaks caused by these viruses cannot be certainly projected However, in recent times, the world has come to terms with the devastating impact of mortality and morbidity unleashed by two viral agents within these distinct viral groups–Dengue virus and Ebola virus. While the mortality rate of the latter is known to be a little over 90% [
 <xref rid="pone.0208907.ref002" ref-type="bibr">2</xref>] in some instances, it is rather the morbidity rate in the former that causes extensive concern as the World Health Organization (WHO) indicated a 30-fold increase in cases since 1960 [
 <xref rid="pone.0208907.ref003" ref-type="bibr">3</xref>].
</p>
